School of Medicine
Showing 321-330 of 935 Results
-
I Lehman
William M. Hume Professor in the School of Medicine, Emeritus
Current Research and Scholarly InterestsWe study Herpes simplex virus type 1 as a model eukaryotic chromosome for the analysis of eukaryotic DNA replication and recombination
-
John Leikauf
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsI am interested in better understanding the heterogeneous cognitive and electrophysiological abnormalities in children with ADHD and the many other conditions that commonly co-occur with ADHD. The long-term goal is to be able to better target treatments to specific deficits in order to promote long-term health and well-being and improve outcomes that matter to individuals and families suffering from these disorders.
-
Ramrada Lekwuttikarn MD
Clinical Instructor, Dermatology
BioRamrada Lekwuttikarn, MD is a subspecialty-trained pediatric dermatologist and clinical investigator in the Division of Pediatric Dermatology at Stanford University School of Medicine and Lucile Packard Children’s Hospital Stanford. She serves as a Research Scientist and Clinical Instructor, with clinical and research expertise focused on vascular anomalies, genetic skin disorders, and inflammatory skin diseases.
Dr. Lekwuttikarn received her medical degree from Ramathibodi Hospital, Mahidol University, Thailand, where she also completed pediatric residency training. She subsequently completed fellowship training in pediatric dermatology at King Chulalongkorn Memorial Hospital, followed by clinical research fellowships at Children’s Hospital of Philadelphia and Stanford University. Prior to joining Stanford faculty, she served as Chief of the Pediatric Dermatology Division and Assistant Professor at Ramathibodi Hospital.
Her research centers on genotype-guided therapies, targeted molecular treatments, and translational clinical trials for complex pediatric dermatologic conditions. She serves as a sub-investigator on multiple Phase II and III clinical trials, including studies investigating MEK inhibitors, PI3K pathway inhibitors, topical statins, and novel biologic therapies for vascular anomalies, epidermolysis bullosa, and inflammatory skin diseases. Her work has been presented at international conferences including the Society for Pediatric Dermatology and the ISSVA World Congress, and published in peer-reviewed journals such as JAMA Dermatology, The Journal of Investigative Dermatology, Pediatrics, and The Journal of Clinical Investigation.
Dr. Lekwuttikarn is committed to advancing innovative, precision-based therapies while delivering compassionate, multidisciplinary care for children with complex skin disorders.
